Changes in the management of vulval cancer.
Vulval carcinoma is relatively rare. The disease spreads from the vulva through embolization to the locoregional lymphatic station, the inguinofemoral nodes. Prior to this event cure can be achieved, but rarely predicted with certainty. This chapter reviews current therapeutic knowledge and recognizes the increasing importance of individualization of a treatment plan. The adoption of these principles will hopefully evolve a pattern of care that leads to a decrease in morbidity for those women with early tumours and less morbid but more effective strategies for those with advanced disease.
Dhar
Kalyan K
KK
Department of Gynaecological Oncology, Saint Mary's Hospital, Portsmouth, UK.
Woolas
Robert P
RP
D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007264:Inguinal Canal; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery*; D009367:Neoplasm Staging; D010388:Pelvis; D021701:Sentinel Lymph Node Biopsy; D014846:Vulvar Neoplasms / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery*